POMC and depressive disorder: Significant reduction in symptoms of depression (KMI; K-5) after two months of treatment with 2 g daily dose of Maca-GO was parallel with significant reduction in CT and ACTH in the AMMPP sequence group only, while in APPMM group, reduction in symptom of depression was apparent without reduction in CT and ACTH levels.